Towards a New Challenge in TB Control: Development of Antibody-Based Protection

Acosta, Armando; López, Yamile Lira; Nor, Norazmi Mohd; Hernández-Pando, Rogelio; Álvarez, Nadine; Sarmiento, María E.

doi:10.5772/31835

Cited by 2 publications

(1 citation statement)

References 82 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The growing consensus about the protective role of antibodies in mycobacterial infections [294][295][296][297][298] suggests the potential use of antibody formulations for the treatment of PNTM. Previous studies have demonstrated the role of humoral immune responses in the defence against mycobacteria in humans [299][300][301].…”

Section: (B) Treatmentmentioning

confidence: 99%

Pulmonary non-tuberculous mycobacterial infections: current state and future management

Chin

Sarmiento

Alvarez-Cabrera

et al. 2019

Eur J Clin Microbiol Infect Dis

Self Cite

View full text Add to dashboard Cite

Currently, there is a trend of increasing incidence in pulmonary non-tuberculous mycobacterial infections (PNTM) together with a decrease in tuberculosis (TB) incidence, particularly in developed countries. The prevalence of PNTM in underdeveloped and developing countries remains unclear as there is still a lack of detection methods that could clearly diagnose PNTM applicable in these low-resource settings. Since non-tuberculous mycobacteria (NTM) are environmental pathogens, the vicinity favouring host-pathogen interactions is known as important predisposing factor for PNTM. The ongoing changes in world population, as well as socio-political and economic factors, are linked to the rise in the incidence of PNTM. Development is an important factor for the improvement of population well-being, but it has also been linked, in general, to detrimental environmental consequences, including the rise of emergent (usually neglected) infectious diseases, such as PNTM. The rise of neglected PNTM infections requires the expansion of the current efforts on the development of diagnostics, therapies and vaccines for mycobacterial diseases, which at present, are mainly focused on TB. This review discuss the current situation of PNTM and its predisposing factors, as well as the efforts and challenges for their control.

show abstract

Section: (B) Treatmentmentioning

confidence: 99%

Pulmonary non-tuberculous mycobacterial infections: current state and future management

Chin

Sarmiento

Alvarez-Cabrera

et al. 2019

Eur J Clin Microbiol Infect Dis

Self Cite

View full text Add to dashboard Cite

show abstract

The Role of Antibodies in the Defense Against Tuberculosis

Acosta¹,

López²,

Nor³

et al. 2013

Tuberculosis - Current Issues in Diagnosis and Management

Self Cite

View full text Add to dashboard Cite

Please use Adobe Acrobat Reader to read this book chapter for free. Just open this same document with Adobe Reader. If you do not have it, you can download it here. You can freely access the chapter at the Web Viewer here. Tuberculosis-Current Issues in Diagnosis and Management 58 Please use Adobe Acrobat Reader to read this book chapter for free. Just open this same document with Adobe Reader. If you do not have it, you can download it here. You can freely access the chapter at the Web Viewer here.

show abstract

Towards a New Challenge in TB Control: Development of Antibody-Based Protection

Cited by 2 publications

References 82 publications

Pulmonary non-tuberculous mycobacterial infections: current state and future management

Pulmonary non-tuberculous mycobacterial infections: current state and future management

The Role of Antibodies in the Defense Against Tuberculosis

Contact Info

Product

Resources

About